Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
Top Cited Papers
- 1 May 2020
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (3), 251-254
- https://doi.org/10.1016/j.dsx.2020.03.012
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trialThe Lancet Infectious Diseases, 2011
- Use of chloroquine in viral diseasesThe Lancet Infectious Diseases, 2011
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese AdultsPLoS Neglected Tropical Diseases, 2010
- Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn MiceAntimicrobial Agents and Chemotherapy, 2009
- On Chikungunya Acute Infection and Chloroquine TreatmentVector-Borne and Zoonotic Diseases, 2008
- Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS)1Biology of Reproduction, 2006
- Effects of chloroquine on viral infections: an old drug against today's diseasesThe Lancet Infectious Diseases, 2003
- Antihistaminics, local anesthetics, and other amines as antiviral agents.Proceedings of the National Academy of Sciences of the United States of America, 1981
- Effect of chloroquine on the growth of animal virusesArchiv für die gesamte Virusforschung, 1972
- Comparison of the Antiviral Activity in vitro of some Non-steroidal Anti-inflammatory DrugsJournal of General Virology, 1969